FMR LLC reports 1.4% stake in Crinetics Pharma
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FMR LLC and Abigail P. Johnson report beneficial ownership of CRINETICS PHARMACEUTICALS INC common stock on an amended Schedule 13G. FMR LLC reports beneficial ownership of 1,439,890.88 shares, representing 1.4% of the common stock outstanding, with 1,438,730.00 shares having sole voting power and 1,439,890.88 shares subject to sole dispositive power.
Abigail P. Johnson reports no sole or shared voting power, but reports 1,439,890.88 shares subject to sole dispositive power, also equal to 1.4% of the class. The filing notes that one or more other persons have rights to receive dividends or sale proceeds for these shares, and no such person has more than five percent of the outstanding common stock.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
parent holding company financial
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of CRNX common stock does FMR LLC report owning?
What ownership does Abigail P. Johnson report in CRNX?
Does FMR LLC report owning more than 5% of CRNX stock?
What type of filing is this CRNX ownership report by FMR LLC?
AI-generated analysis. How Rhea-AI works. Not financial advice.